DK1753440T3 - Oral administrationsform indeholdende probiotiske bakterier - Google Patents

Oral administrationsform indeholdende probiotiske bakterier

Info

Publication number
DK1753440T3
DK1753440T3 DK05746643T DK05746643T DK1753440T3 DK 1753440 T3 DK1753440 T3 DK 1753440T3 DK 05746643 T DK05746643 T DK 05746643T DK 05746643 T DK05746643 T DK 05746643T DK 1753440 T3 DK1753440 T3 DK 1753440T3
Authority
DK
Denmark
Prior art keywords
probiotic bacteria
administration containing
oral form
containing probiotic
oral
Prior art date
Application number
DK05746643T
Other languages
Danish (da)
English (en)
Inventor
Stefan Henke
Iris Manneck
Markus Rudolph
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34980007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1753440(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1753440T3 publication Critical patent/DK1753440T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK05746643T 2004-05-28 2005-05-04 Oral administrationsform indeholdende probiotiske bakterier DK1753440T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004026706A DE102004026706A1 (de) 2004-05-28 2004-05-28 Orale Darreichungsform enthaltend probiotische Bakterien
PCT/EP2005/004835 WO2005117921A1 (de) 2004-05-28 2005-05-04 Orale darreichungsform enthaltend probiotische bakterien

Publications (1)

Publication Number Publication Date
DK1753440T3 true DK1753440T3 (da) 2008-06-02

Family

ID=34980007

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05746643T DK1753440T3 (da) 2004-05-28 2005-05-04 Oral administrationsform indeholdende probiotiske bakterier

Country Status (20)

Country Link
US (2) US20090162322A1 (ru)
EP (1) EP1753440B1 (ru)
JP (1) JP5070043B2 (ru)
KR (1) KR101289413B1 (ru)
CN (1) CN1956724B (ru)
AT (1) ATE386534T1 (ru)
AU (1) AU2005249187B2 (ru)
BR (1) BRPI0511615B8 (ru)
CA (1) CA2568171C (ru)
CY (1) CY1107399T1 (ru)
DE (2) DE102004026706A1 (ru)
DK (1) DK1753440T3 (ru)
ES (1) ES2299034T3 (ru)
MX (1) MXPA06013686A (ru)
PL (1) PL1753440T3 (ru)
PT (1) PT1753440E (ru)
RU (1) RU2376023C2 (ru)
SI (1) SI1753440T1 (ru)
WO (1) WO2005117921A1 (ru)
ZA (1) ZA200610768B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5576606B2 (ja) * 2005-05-18 2014-08-20 ディーエスエム アイピー アセッツ ビー．ブイ． 微生物の腸内投与用組成物
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
KR101474188B1 (ko) * 2006-10-02 2014-12-17 듀폰 뉴트리션 바이오사이언시즈 에이피에스 질병의 발병률 및 지속기간의 감소에 사용하기 위한 프로바이오틱
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
MX2012001765A (es) 2009-08-14 2012-03-07 Danisco Microorganismos deshidratados recubiertos con estabilidad y viabilidad mejoradas.
US20130004475A1 (en) 2010-03-12 2013-01-03 Misaki Hatanaka Agent for increasing bifidobacteria and reducing the decrease of bifidobacteria in large intestine
CA2831345C (en) 2011-05-06 2022-05-03 Organobalance Medical Ag Lactic acid bacterial strains that coaggregate with staphylococcus aureus, and compositions and uses of the strains
EP2710115B1 (de) 2011-05-16 2017-12-27 Belano Medical AG Neue milchsäurebakterien und diese enthaltende zusammensetzungen gegen bakterielle erkältungen
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
RU2491079C1 (ru) * 2012-07-13 2013-08-27 Федеральное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Комплексный пробиотический препарат и способ его получения
TWI481409B (zh) * 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
US10849940B2 (en) * 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
KR101470995B1 (ko) * 2013-08-30 2014-12-09 주식회사 바이오리쏘스 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
RU2736823C2 (ru) 2014-07-01 2020-11-20 ПРОБИ ЮЭсЭй, ИНК. Двухслойные таблетки, содержащие пробиотики, с двойным высвобождением
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
US10339273B2 (en) 2015-11-18 2019-07-02 Warsaw Orthopedic, Inc. Systems and methods for pre-operative procedure determination and outcome predicting
CN111870617B (zh) * 2019-11-04 2022-06-10 深圳碳云智能数字生命健康管理有限公司 肠道益生菌补剂配方的确定方法、装置、存储介质及处理器
CN111110703B (zh) * 2020-01-13 2020-12-01 华中农业大学 动物双歧杆菌及其制备的复合菌制剂在制备治疗或预防禽流感病毒感染的药物中的应用
CN114917259B (zh) * 2022-02-15 2023-10-13 中国科学院上海硅酸盐研究所 一种二维氢硅烯-微生物复合材料及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58157726A (ja) * 1982-03-11 1983-09-19 Shin Etsu Chem Co Ltd 固形薬剤用腸溶性コ−テイング剤組成物
JPH024016A (ja) * 1988-06-20 1990-01-09 Fujitsu Ltd 半導体集積回路
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IT1265092B1 (it) * 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
CN1156271C (zh) * 2000-04-29 2004-07-07 中国科学技术大学 一种固体药剂用高分子包衣粉及其制备方法
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation

Also Published As

Publication number Publication date
CA2568171C (en) 2013-09-17
DE102004026706A1 (de) 2005-12-15
SI1753440T1 (sl) 2008-08-31
AU2005249187B2 (en) 2011-03-17
MXPA06013686A (es) 2007-02-13
CA2568171A1 (en) 2005-12-15
DE502005002929D1 (de) 2008-04-03
EP1753440B1 (de) 2008-02-20
EP1753440A1 (de) 2007-02-21
JP5070043B2 (ja) 2012-11-07
BRPI0511615B8 (pt) 2021-05-25
PL1753440T3 (pl) 2008-05-30
RU2376023C2 (ru) 2009-12-20
CN1956724B (zh) 2013-08-28
KR20070024539A (ko) 2007-03-02
RU2006145056A (ru) 2008-07-10
BRPI0511615A (pt) 2008-01-02
AU2005249187A1 (en) 2005-12-15
JP2008500294A (ja) 2008-01-10
ES2299034T3 (es) 2008-05-16
ZA200610768B (en) 2008-07-30
ATE386534T1 (de) 2008-03-15
BRPI0511615B1 (pt) 2018-01-23
US20090162322A1 (en) 2009-06-25
CN1956724A (zh) 2007-05-02
WO2005117921A1 (de) 2005-12-15
US20190110997A1 (en) 2019-04-18
PT1753440E (pt) 2008-05-28
CY1107399T1 (el) 2012-12-19
KR101289413B1 (ko) 2013-08-07

Similar Documents

Publication Publication Date Title
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
TW200700009A (en) Active compound combinations having insecticidal and acaricidal properties
MA32876B1 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
LTPA2018502I1 (lt) Per burną vartojamos kladribino kompozicijos
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
MX2010002285A (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas.
TW200732349A (en) Anti-OX40L antibodies and methods using same
MX2010001849A (es) Depsipeptidos ciclicos.
MX2007005202A (es) Polisacaridos de estreptococo modificados y usos de los mismos.
ATE407215T1 (de) Enzymatische demethylierung von flavonoiden
EA201001024A1 (ru) Обработка растений банана и картофеля с помощью новой противогрибковой композиции
WO2008064345A3 (en) Microorganism killing compounds
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MY148276A (en) Long-term feed- elderly
ATE433459T1 (de) Desoxo-nonadepsipeptide
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
RS51896B (en) The use of glucose isomerase in the treatment of fructose intolerance
ATE455789T1 (de) Substituierte nonadepsipeptide
AU316238S (en) Lawning applicator for microbiological cultures
BRPI0817090A2 (pt) Método de cultura e uma espécie bacteriana da família anaplasmataceae, e, composição.
DK1633373T3 (da) Farmaceutisk sammensætning indeholdende glucan hidrørende fra mikroalger
TW200613604A (en) Preparation of fabrics having lotus leaf effect and fabrics having lotus leaf effect
UA2493U (uk) Штам бактерій enterococсus faecium нм-5 для виготовлення бактерійних препаратів
AU316107S (en) Blower pulleys